This paper proposes a solution to the out-of band oscillation signal and in-band low transmitter power output that occurrs during the low-temperature operation test for the new mine detector GPR signal transmission and reception module. Tests were performed by applying the optimal values of capacitors and inductors through circuit analysis simulation under the limited space, as a result, it was confirmed that the gain and return loss were improved at all-band thereby preventing oscillation signal and low transmitter power output.

사회기반 시설물의 노후화에 대응해 이상 징후를 파악하고 유지보수를 위한 최적의 의사결정을 내리기 위해선 디지털 기반 SOC 시설물 유지관리 시스템의 개발이 필수적인데, 디지털 SOC 시스템은 장기간 구조물 계측을 위한 IoT 센서 시스템과 축적 데이터 처 리를 위한 클라우드 컴퓨팅 기술을 요구한다. 본 연구에서는 구조물의 다물리량을 장기간 측정할 수 있는 IoT센서와 클라우드 컴퓨팅 을 위한 서버 시스템을 개발하였다. 개발 IoT센서는 총 3축 가속도 및 3채널의 변형률 측정이 가능하고 24비트의 높은 해상도로 정밀 한 데이터 수집을 수행한다. 또한 저전력 LTE-CAT M1 통신을 통해 데이터를 실시간으로 서버에 전송하여 별도의 중계기가 필요 없 는 장점이 있다. 개발된 클라우드 서버는 센서로부터 다물리량 데이터를 수신하고 가속도, 변형률 기반 변위 융합 알고리즘을 내장하 여 센서에서의 연산 없이 고성능 연산을 수행한다. 제안 방법의 검증은 2개소의 실제 교량에서 변위계와의 계측 결과 비교, 장기간 운 영 테스트를 통해 이뤄졌다.

육제품에 사용되는 합성 항산화제를 대체할 천연물질에 관한 관심이 높아지고 있다. 본 연구는 냉장 저장 중 아스타잔틴(AX)의 첨가가 유화형소시지의 산화 안정성 및 품질 특성에 미치는 영향을 조사하기 위해 무첨가구인 대조구, 500 mg/kg BHT (Butylated hydroxytoluene), 및 80 mg/kg AX으로 처리하였다. AX의 첨가는 유화형소시지의 pH, 유화 안정성 및 가열 수율에 유의적인 영향을 미치지 않았다(p>0.05). 그러나 육색의 경우 아스타잔틴 첨가구의 초기(day 1) 색상유지력은 합성 항산화제인 BHT와 동일하였고, 적색도는 높게 나타났다(p<0.05). 항산화 능력에서, 처리구간 단백질 산화는 유의 적인 차이가 없었다. 지질 산화의 경우 저장 종료시(day 14) BHT 처리구에서 가장 낮은 값을 나타냈으나 AX 첨가구 또한 무첨가구인 대조구보다 매우 낮게 나타났다(p<0.05). 한편, 경도는 저장 초기에 비해 저장 종료시 BHT와 AX 처리구들에서 대조구에 비해 낮게 나타났다(p<0.05). 그러므로 천연물질인 아스타잔틴은 기존에 사용되는 합성 항산화제인 BHT를 대체하여 항산화제의 역할뿐만 아니라 육제품의 색상 증진제로도 활용 가능할 것으로 판단된다.

The Australian genus Logasa Chandler was described in 2001 based on Logasa novaeangila Chandler 2001. Other two species, Logasa tricolor (Oke 1928) and Logasa ventralis (Oke 1928) were originally described as the genus Sagola, and transferred to Logasa by Chandler. During revisionary study using 140 museum specimens, additional three new species was recognized. After type examination of L. tricolor and L. ventralis, we found that they have different diagnostic characters for generic level such as foveal system and male genitalia. However, their diagnostic characters are not included any known faronite genus. Australian faronite fauna has numerous undescribed species. They will revise with other undescribed species for a following study.

The microstructure, phase, and mechanical properties of three aged porcelain insulators which were manufactured in different years (1973, 1995 and 2008) and which were used in the field for different amounts of time, were investigated. With X-ray 3D computed tomography (CT), defects with ~mm size can be detected without destroying the aged insulators. Defects of small specimens, which are cut from the aged insulators and polished, are analyzed with optical and scanning electron microscopy (OM and SEM), and defects of um size are detected by OM and SEM. The number and size of defects in all the aged insulators are similar. Porcelain insulators manufactured in 1973 contain more SiO2 (quartz and cristobalite) than those manufactured in 2008. Those manufactured in 2008 contain more Al2O3 than those manufactured earlier. The Vickers hardness of the insulator manufactured in 1973 has the lowest value. The formation of the cristobalite (SiO2) in the insulator manufactured in 1973 which can come from the phase transformation of quartz can cause stress in the insulator by formation of microcracks, which can lead to the low hardness of the insulator.

Bcl-2 protects tumor cells from the apoptotic effects of various anti-neoplastic agents. Increased expression of Bcl-2 has been associated with a poor response to chemotherapy in various malignancies, including leukemia. Hence, bypassing the resistance conferred by anti-apoptotic factors such as Bcl-2 represents an attractive therapeutic strategy against cancer cells, including leukemic cells. This study was undertaken to examine whether the anticancer drug, cisplatin and the synthetic chenodeoxycholic acid (CDCA) derivative, HS-1200 show anti-tumor activity in U937 and U937/Bcl-2 cells. Viability assays revealed that HS-1200 overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells. Various apoptosis assessment assays further demonstrated that HS-1200 overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells by inducing apoptosis. In addition HS-1200, but not cisplatin, overcomes the anti-apoptotic effects of Bcl-2 in Bcl-2 over-expressing human leukemic cells (U937/Bcl-2 cells). Notably, we observed that the HS-1200-induced formation of mature promyelocytic leukemia (PML) nuclear bodies (NBs) correlates with a suppression of the anti-apoptotic effects of Bcl-2 in human leukemic cells over-expressing this protein (U937/Bcl-2 cells). Furthermore, HS-1200 was found to induce the association between PML and SUMO-1, Daxx, Sp100, p53 or CBP in the aggregated PML-NBs of U937/Bcl-2 cells. Thus, PML protein and the formation of mature PML-NBs could be considered as therapeutic targets that may help to bypass the resistance to apoptosis conferred by Bcl-2. Elucidating the exact mechanism by which PML regulates Bcl-2 will require further work.

Eugenol (4-allyl-2-methoxyphenol) is a naturally occurring phenolic compound that is widely used in dentistry as a component of zinc oxide eugenol cement that is commonly applied to the mouth environment. Cisplatin is one of the most potent known anticancer agents and shows significant clinical activity against a variety of solid tumors. This study was undertaken to investigate the synergistic apoptotic effects of co-treatments with eugenol and cisplatin on human melanoma (G361) cells. To investigate whether this co-treatment efficiently reduces the viability of G361 cells compared with each single treatment, an MTT assay was conducted. The induction and augmentation of apoptosis were confirmed by DNA electrophoresis, Hoechst staining and an analysis of DNA hypoploidy. Western blot analysis and immunofluorescent staining were also performed to evaluate the expression levels and the translocation of apoptosis-related proteins following this co-treatment. Furthermore, proteasome activity and mitochondrial membrane potential (MMP) changes were also assayed. The results indicated that a co-treatment with eugenol and cisplatin induced multiple pathways and processes associated with an apoptotic response in G361 cells including nuclear condensation, DNA fragmentation, a reduction in MMP and proteasome activity, the increase and decrease of Bax and Bcl-2, a decreased DNA content, the release of cytochrome c into the cytosol, the translocation of AIF and DFF40 (CAD) into the nucleus, and the activation of caspase-9, caspase-7, caspase-3, PARP and DFF45 (ICAD). In contrast, separate treatments of 300 μM eugenol or 3 μM cisplatin for 24 h did not induce apoptosis. Our present data thus suggest that a combination therapy of eugenol and cisplatin is a potential treatment strategy for human melanoma.

염화칼슘 농도를 달리한 쌈무의 조직감 개선 효과, 물리·화학적 특성 및 관능평가를 비교하였다. 염화칼슘 첨가 후 저장 전 쌈무들의 pH와 총산도 범위는 각각 약 3.8~4.0와 2.7~3.0(%, w/v)이었으며, 28일 동안의 저장기간 동안 저장 온도 4℃와 50℃의 시료들은 저장 전 초기 pH와 총산도의 범위를 유지하였다. 그러나 저장온도 25℃에서 쌈무 시료들은 저장 전 초기 pH 범위보다 0.5가 낮아졌고 총산도는 1.9~2.2(%, w/v)가 증가되어졌다. 염화칼슘의 첨가에 따른 쌈무 시료들의 색도를 측정한 결과, 28일 저장동안 4℃에서 저장된 쌈무 시료들은 현저한 차이를 나타내었으나(△E값 1.66~8.21) 50℃에서 저장된 시료들은 다른 계통의 색으로(△E값 23~27) 큰 변화를 보였다. 쌈무 시료들의 경도에 있어서, 저장온도 4℃와 25℃에서 28일 동안 저장된 쌈무 시료들의 경도는 저장 전 쌈무 시료들의 경도와 큰 차이를 보이지 않았고, 50℃에서는 염화칼슘 처리량이 증가 할수록 경도가 높게 유지되고 있음을 확인 할 수 있었다. 쌈무 시료들의 씹힘성에 있어서는 전반적으로 경도의 결과와 유사한 경향을 보였다. 이로써 염화칼슘처리로 쌈무의 조직감을 향상시킬 수 있음을 확인하였다. 4℃에서 28일 동안 저장된 쌈무 시료들의 관능평가 결과, 0.4% 염화칼슘이 첨가된 쌈무 시료가 맛, 경도와 전반적인 기호도에서 가장 높은 점수를 받아 유통 저장기간 동안 관능품질을 유지하면서 쌈무의 조직감을 유지시킬 수 있는 염화칼슘 첨가량이라 판단된다.